Convalescent Plasma to Stem Coronavirus (CSSC-001)

Exclusion Criteria

• •1. Receipt of any blood product in past 120 days.
• •2. Medical, psychiatric,cognitive illness or recreational drug/alcohol use that in the opinion of the principal investigator, would affect subject safety and/or compliance.
• •3. Symptoms consistent with COVID-19 infection (fevers, acute onset cough, shortness of breath) at time of screening.
• •4. Laboratory evidence of COVID-19 infection at time of screening.
• •5. History or known laboratory evidence of previous COVID-19 infection.
• •6. History of prior reactions to transfusion blood products.
• •7. Inability to complete therapy with the study product within 24 hours after randomization.